Abstract
The relevance of the topic is determined by the increase in morbidity among the child population. Bronchial asthma is one of the most common childhood diseases, a formidable complication of which is asthmatic status, as well as the fact that the timely treatment of the disease, taking into account its severity and characteristics, the use of modern effective drugs are the key to the success of therapy, allow you to quickly stabilize the child's condition and further control bronchial asthma.
Highlights
Bronchial asthma in children is one of the most pressing medical and social problems
The urgency of bronchial asthma in children is characterized by the transition of the disease to a chronic form, and by the fact that the disease leads to an increase in disability among children, which negatively affects the resources of health care facilities
Referring to scientific articles and medical literature published by scientists, it becomes clear that the primary and general incidence of bronchial asthma among children (Fig. 1) and adolescents (Fig. 2) in the regions of Uzbekistan largely depends on the climatic conditions, the economic profile of the region and the level provision of the population with medical care
Summary
Bronchial asthma in children is one of the most pressing medical and social problems. 3-7% suffer from bronchial asthma, in Central Asia - 1.4%, in Tashkent 2.9% of the population per 1000 inhabitants. In Germany and in other Western and central foreign countries, along with malnutrition, other factors, such as stress, lack of physical activity, lead to an increase in chronic diseases in children, while in Uzbekistan, the main cause of bronchial asthma in children is bad ecology. Referring to scientific articles and medical literature published by scientists, it becomes clear that the primary and general incidence of bronchial asthma among children (Fig. 1) and adolescents (Fig. 2) in the regions of Uzbekistan largely depends on the climatic conditions, the economic profile of the region and the level provision of the population with medical care
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The American Journal of Medical Sciences and Pharmaceutical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
